Colon & Rectal Surgery Oral Boards Study Guide

Total Page:16

File Type:pdf, Size:1020Kb

Colon & Rectal Surgery Oral Boards Study Guide Fall 08 Fall 13 Colon & Rectal Surgery Oral Boards Study Guide Allen Kamrava Colon and Rectal Surgeon, Cedar Sinai Medical Center Los Angeles Colon and Rectal Surgical Associates INTRODUCTION The year following fellowship can be exhausting. For many, we are relocating to what will hopefully be a permanent location. We are transitioning into our new practices, and soon operating on patients where we are the ones responsible if any complications were to occur. At the same time, we are building a network of practitioners whom we rely on and hope that they reflexively will rely on us as well. The written board exam quickly approaches and soon thereafter the oral board examination. It is incredibly difficult to set time aside to study. In fact, I would say the most difficult time I ever had preparing for examinations was once I was within my own practice. You are juggling numerous responsibilities and the very last thing you want to deal with is yet another exam. I spent time during my fellowship, as well as during my first year of practice, re-reading both the ASCRS textbook and the textbook “Improved Outcomes in Surgery.” The latter of the textbooks, “Improved Outcomes” to me proved to be an invaluable read for preparation for this exam, and I would urge anybody who is considering what to read to consider this text. It is by no means voluminous and instead focuses on exactly these questions. As prior, the notes below are my own notes. And thus, they are chalk full of typos and errors. Some may be ridiculous. I haven’t spent time proofreading these notes – in this regards, they are a “first draft” of notes. Nevertheless, I compiled below all the topics and notes I thought necessary to prepare for my oral boards for CRS. Other than having read the texts to make these notes, these notes constituted my preparation for the orals examinations. I provide them because I do believe there is little to guide the residents/fellows in this regard. I do not think that by themselves, these notes will suffice for a well rounded understanding of the topics in hand. These notes absolutely will not suffice for the written exam, as they lack the detail and many of the topics necessary to pass that specific exam. As always, I cannot thank enough my wife Dalia, who has supported me through all of this. Especially on the days and nights I was absolutely fed up with sitting and reading, she pushed me forward. And my 2 daughters, for the time with me they have unknowingly given up. I will be repaying you both, in interest, from here on forward. If you have any thoughts or concerns, please let me know. I wish you all the best. Allen Kamrava, M.D. TABLE OF CONTENTS Anal Cancer ...................................................................................................................................................................................... 1 Anal Stricture ................................................................................................................................................................................... 3 Anastomatic Leak ............................................................................................................................................................................ 4 Appendiceal Tumors ........................................................................................................................................................................ 5 Carcinoid .......................................................................................................................................................................................... 6 Colon Cancer .................................................................................................................................................................................... 7 Colonic Volvulus ............................................................................................................................................................................ 12 Constipation .................................................................................................................................................................................. 14 Medical Mgmt of Inflammatory Bowel Disease ............................................................................................................................ 16 Crohn’s ........................................................................................................................................................................................... 19 Diverticulitis ................................................................................................................................................................................... 20 Endometriosis ................................................................................................................................................................................ 22 Familial Adenomatous Polyposis ................................................................................................................................................... 23 Fecal Incontinence ......................................................................................................................................................................... 25 Fissure ............................................................................................................................................................................................ 27 Fistula-in-Ano ................................................................................................................................................................................ 28 GI Bleed ......................................................................................................................................................................................... 30 Hemorrhoids .................................................................................................................................................................................. 31 HNPCC - Hereditary Nonpolyposis Colon Cancer .......................................................................................................................... 33 Ileostomy Complications - Ischemia .............................................................................................................................................. 34 IPAA Complications ....................................................................................................................................................................... 36 Polypectomy .................................................................................................................................................................................. 38 Pediatric Anorectal Conditions ...................................................................................................................................................... 40 Pelvic Floor Disorders .................................................................................................................................................................... 42 Pilonidal Disease ............................................................................................................................................................................ 43 PreSacral Tumors ........................................................................................................................................................................... 44 Pruritis Ani ..................................................................................................................................................................................... 46 Rectal Cancer ................................................................................................................................................................................. 47 Abdominoperineal Resection ........................................................................................................................................................ 50 Adjuvant Therapy for Colorectal CA .............................................................................................................................................. 51 Indications and Outcomes for Treatment of Recurrent Rectal CA and Colorectal Liver and Lung Metastasis ............................. 52 Radiation Proctitis ......................................................................................................................................................................... 54 Rectal Prolapse (Rectal Procidentia) ............................................................................................................................................. 55 RectoVaginal Fistula ...................................................................................................................................................................... 56 Solitary Rectal Ulcer Syndrome ..................................................................................................................................................... 58 2 Sexually Transmitted Diseases ...................................................................................................................................................... 59 Trauma ..........................................................................................................................................................................................
Recommended publications
  • Hepatic Surgery
    Hepatic Surgery Honorary Editors: Tan To Cheung, Long R. Jiao Editors: Zhiming Wang, Giovanni Battista Levi Sandri, Alexander Parikh Associate Editors: Yiming Tao, Michael D. Kluger, Romaric Loffroy Editors: Zhiming Wang, Giovanni Battista Levi Sandri, Levi Battista Giovanni Alexander Parikh Hepatic Surgery Honorary Editors: Tan To Cheung, Long R. Jiao Editors: Zhiming Wang, Giovanni Battista Levi Sandri, Alexander Parikh Associate Editors: Yiming Tao, Michael D. Kluger, Romaric Loffroy AME Publishing Company Room C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong Information on this title: www.amegroups.com For more information, contact [email protected] Copyright © AME Publishing Company. All rights reserved. This publication is in copyright. Subject to statutory exception and to the provisions of relevant collective licensing agreements, no reproduction of any part may take place without the written permission of AME Publishing Company. First published in 2018 Printed in China by AME Publishing Company Editors: Zhiming Wang, Giovanni Battista Levi Sandri, Alexander Parikh Hepatic Surgery (Hard Cover) ISBN: 978-988-78919-1-8 AME Publishing Company, Hong Kong AME Publishing Company has no responsibility for the persistence or accuracy of URLs for external or third-party internet websites referred to in this publication, and does not guarantee that any content on such websites is, or will remain, accurate or appropriate. The advice and opinions expressed in this book are solely those of the authors and do not necessarily represent the views or practices of the publisher. No representation is made by the publisher about the suitability of the information contained in this book, and there is no consent, endorsement or recommendation provided by the publisher, express or implied, with regard to its contents.
    [Show full text]
  • A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia
    Protocol 01-2017: RFA for Anal Intraepithelial Neoplasia A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using The BARRX™ Anorectal Wand (Clinical Protocol 01-2017) AUGUST 31, 2017 Page 1 of 40 Protocol 01-2017: RFA for Anal Intraepithelial Neoplasia PROTOCOL SIGNATURE PAGE I, , Principal Investigator at site , agree to conduct and follow this protocol: PROTOCOL 01-2017: A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for Anal Intraepithelial Neoplasia using the Barrx™ Anorectal Wand as written according to FDA guidelines. I understand that no deviations from the above protocol may be made without written permission from the Protocol Chair(s). _________________________________ _____________________ Signature Date (mm/dd/yyyy) Page 2 of 40 Protocol 01-2017: RFA for Anal Intraepithelial Neoplasia P ROT O COL S U M M ARY Title A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for Anal Intraepithelial Neoplasia using the Barrx™ Anorectal Wand Design Multi-center prospective trial involving up to 70 subjects Subject Population HIV-positive and HIV-negative subjects with intra-anal intraepithelial neoplasia (AIN) containing at least one high- grade squamous intraepithelial lesions (HSIL) involving the squamocolumnar junction (SCJ). Objective Assess the safety, and efficacy of circumferential radiofrequency ablation (RFA) to the anal canal using the FDA cleared Barrx™ Anorectal Wand to eradicate anal
    [Show full text]
  • Practice Parameters for the Treatment of Patients with Dominantly Inherited Colorectal Cancer
    Practice Parameters For The Treatment Of Patients With Dominantly Inherited Colorectal Cancer Diseases of the Colon & Rectum 2003;46(8):1001-1012 Prepared by: The Standards Task Force The American Society of Colon and Rectal Surgeons James Church, MD; Clifford Simmang, MD; On Behalf of the Collaborative Group of the Americas on Inherited Colorectal Cancer and the Standards Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons is dedicated to assuring high quality patient care by advancing the science, prevention, and management of disorders and diseases of the colon, rectum, and anus. The standards committee is composed of Society members who are chosen because they have demonstrated expertise in the specialty of colon and rectal surgery. This Committee was created in order to lead international efforts in defining quality care for conditions related to the colon, rectum, and anus. This is accompanied by developing Clinical Practice Guidelines based on the best available evidence. These guidelines are inclusive, and not prescriptive. Their purpose is to provide information on which decisions can be made, rather than dictate a specific form of treatment. These guidelines are intended for the use of all practitioners, health care workers, and patients who desire information about the management of the conditions addressed by the topics covered in these guidelines. Practice Parameters for the Treatment of Patients With Dominantly Inherited Colorectal Cancer Inherited colorectal cancer includes two main syndromes in which predisposition to the disease is based on a germline mutation that may be transmitted from parent to child.
    [Show full text]
  • Lower Gastrointestinal Bleeding
    Journal of Experimental and Clinical Medicine https://dergipark.org.tr/omuJecm Re view Article J Exp Clin Med 2021; 38(S1): 23-32 doi: 10.52142/omujecm.38.si.gastro.3 Lower gastrointestinal bleeding Serkan ÖCAL1,* , Mehmet Mutlu ÇATLI2 1 Department of Gastroenterology, University of Health Sciences Antalya Training and Research Hospital, Antalya, Turkey 2Departmant of Internal Medicine, Antalya Training and Research Hospital, Antalya, Turkey Received: 13.12.2020 • Accepted/Published Online: 09.01.2021 • Final Version: 18.03.2021 Abstract Bleeding from the lower part of the digestive system that appears as hematocheZia (fresh blood, clot or cherry-colored stool) or melena (dark- colored tarry stool) is called lower gastrointestinal tract bleeding (lower GI bleeding) (or colonic bleeding). In the traditional definition, lower GI bleeding was generally classified as bleeding distal to the TreitZ ligament (duodenojejunal junction) as the border. In the last decade, GI bleeding has adopted three categories in some recent publications: Upper, middle, and lower. According to this category, bleeding from a source between the TreitZ ligament and the ileocecal valve is classified as middle GI bleeding, bleeding from the distal of the ileocecal valve is classified lower GI bleeding. Lower GI bleeding and hospitalization rates increase with aging. Currently, physicians managing lower GI bleeding have many different diagnostic and therapeutic options ranging from colonoscopy and flexible sigmoidoscopy to radiographic interventions such as scintigraphy or angiography. Lower GI bleeding often stops spontaneously and less common than upper GI bleeding. Even though no modality has emerged as the gold standard in the treatment of lower GI bleeding, colonoscopy has several advantages and is generally considered as the preferred initial test in most of the cases.
    [Show full text]
  • Endoscopy Rotation Coordination and Goals and Objects Department of Surgery Stanford School of Medicine (8/15/17, Jnl)
    Endoscopy Rotation Coordination And Goals and Objects Department of Surgery Stanford School of Medicine (8/15/17, jnl) Rotation Director: James Lau, MD ATTENDINGS and CONTACT INFORMATION Cell Phone E-mail Address James Lau, MD (702) 306-8780 [email protected] Homero Rivas, MD MBA (972) 207-2381 [email protected] Dan Azagury, MD (650) 248-3173 [email protected] Shai Friedland, MD [email protected] Andrew Shelton, MD [email protected] Natalie Kirilcuk, MD [email protected] Cindy Kin, MD [email protected] Laren Becker, MD [email protected] Jennifer Pan, MD [email protected] Suzanne Matsui, MD [email protected] Ramsey Cheung, MD [email protected] KEYPOINT The key for this rotation is that you need to show initiative. TEXT Practical Gastrointestinal Endoscopy: The Fundamentals. Sixth Edition. By Peter B. Cotton, Christopher B. Williams, Robert H. Hawes and Brian P. Saunders. You are responsible for the material to enhance your understanding and supplement your past experiences. Lots of pictures and tips and tricks. Quick read. Copy of text available for purchase on Amazon.com or for check out from the Lane Library. Procedure Schedule Monday Tuesday Wednesday Thursday Friday Laren Becker Jennifer Pan Shelton/Kirilcuk/Kin Ramsey Suzanne (VA (VA Colonoscopy 8:00 am Cheung (VA Matsui (VA Livermore) Livermore) (Stanford Endoscopy) Livermore) Livermore) Every other Tuesday Rivas/Lau alternating Upper/Occasional Lower 1 Endoscopy 9a-1p (Stanford Endoscopy) Suzanne Matsui (VA Livermore) The Staff Drs. Becker, Cheung, Pan, and Matsui are gastroenterologists that perform 75% colonoscopies and 25% upper endoscopies at the Livermore location for the Palo Alto VA.
    [Show full text]
  • The American Society of Colon and Rectal Surgeons' Clinical Practice
    CLINICAL PRACTICE GUIDELINES The American Society of Colon and Rectal Surgeons’ Clinical Practice Guideline for the Evaluation and Management of Constipation Ian M. Paquette, M.D. • Madhulika Varma, M.D. • Charles Ternent, M.D. Genevieve Melton-Meaux, M.D. • Janice F. Rafferty, M.D. • Daniel Feingold, M.D. Scott R. Steele, M.D. he American Society of Colon and Rectal Surgeons for functional constipation include at least 2 of the fol- is dedicated to assuring high-quality patient care lowing symptoms during ≥25% of defecations: straining, Tby advancing the science, prevention, and manage- lumpy or hard stools, sensation of incomplete evacuation, ment of disorders and diseases of the colon, rectum, and sensation of anorectal obstruction or blockage, relying on anus. The Clinical Practice Guidelines Committee is com- manual maneuvers to promote defecation, and having less posed of Society members who are chosen because they than 3 unassisted bowel movements per week.7,8 These cri- XXX have demonstrated expertise in the specialty of colon and teria include constipation related to the 3 common sub- rectal surgery. This committee was created to lead inter- types: colonic inertia or slow transit constipation, normal national efforts in defining quality care for conditions re- transit constipation, and pelvic floor or defecation dys- lated to the colon, rectum, and anus. This is accompanied function. However, in reality, many patients demonstrate by developing Clinical Practice Guidelines based on the symptoms attributable to more than 1 constipation sub- best available evidence. These guidelines are inclusive and type and to constipation-predominant IBS, as well. The not prescriptive.
    [Show full text]
  • OT Resource for K9 Overview of Surgical Procedures
    OT Resource for K9 Overview of surgical procedures Prepared by: Hannah Woolley Stage Level 1 2 Gynecology/Oncology Surgeries Lymphadenectomy (lymph node dissection) Surgical removal of lymph nodes Radical: most/all of the lymph nodes in tumour area are removed Regional: some of the lymph nodes in the tumour area are removed Omentectomy Surgical procedure to remove the omentum (thin abdominal tissue that encases the stomach, large intestine and other abdominal organs) Indications for omenectomy: Ovarian cancer Sometimes performed in combination with TAH/BSO Posterior Pelvic Exenteration Surgical removal of rectum, anus, portion of the large intestine, ovaries, fallopian tubes and uterus (partial or total removal of the vagina may also be indicated) Indications for pelvic exenteration Gastrointestinal cancer (bowel, colon, rectal) Gynecological cancer (cervical, vaginal, ovarian, vulvar) Radical Cystectomy Surgical removal of the whole bladder and proximal lymph nodes In men, prostate gland is also removed In women, ovaries and uterus may also be removed Following surgery: Urostomy (directs urine through a stoma on the abdomen) Recto sigmoid pouch/Mainz II pouch (segment of the rectum and sigmoid colon used to provide anal urinary diversion) 3 Radical Vulvectomy Surgical removal of entire vulva (labia, clitoris, vestibule, introitus, urethral meatus, glands/ducts) and surrounding lymph nodes Indication for radical vulvectomy Treatment of vulvar cancer (most common) Sentinel Lymph Node Dissection (SLND) Exploratory procedure where the sentinel lymph node is removed and examined to determine if there is lymph node involvement in patients diagnosed with cancer (commonly breast cancer) Total abdominal hysterectomy/bilateral saplingo-oophorectomy (TAH/BSO) Surgical removal of the uterus (including cervix), both fallopian tubes and ovaries Indications for TAH/BSO: Uterine fibroids: benign growths in the muscle of the uterus Endometriosis: condition where uterine tissue grows on structures outside the uterus (i.e.
    [Show full text]
  • Detail Report
    Supplemental Update Report CR Number: 2012319113 Implementation Date: 16-Jan-19 Related CR: 2012319113 MedDRA Change Requested Add a new SMQ Final Disposition Final Placement Code # Proposed SMQ Infusion related reactions Rejected After Suspension MSSO The proposal to add a new SMQ Infusion related reactions is not approved after suspension. The ICH Advisory Panel did approve this SMQ topic to go into the development phase and it Comment: underwent testing in three databases (two regulatory authorities and one company). However, there were numerous challenges encountered in testing and the consensus decision of the CIOMS SMQ Implementation Working Group was that the topic could not be developed to go into production as an SMQ. Most notably, in contrast to other SMQs, this query could not be tested using negative control compounds because it was not possible to identify suitable compounds administered via infusion that were not associated with some type of reaction. In addition, there is no internationally agreed definition of an infusion related reaction and the range of potential reactions associated with the large variety of compounds given by infusion is very broad and heterogenous. Testing was conducted on a set of around 500 terms, the majority of which was already included in Anaphylactic reaction (SMQ), Angioedema (SMQ), and Hypersensitivity (SMQ). It proved difficult to identify potential cases of infusion related reactions in post-marketing databases where the temporal relationship of the event to the infusion is typically not available. In clinical trial databases where this information is more easily available, users are encouraged to provide more specificity about the event, e.g., by reporting “Anaphylactic reaction” when it is known that this event is temporally associated with the infusion.
    [Show full text]
  • Outpatient Services
    Outpatient Services Coverage of Certain Services in the OUTPATIENT setting only* EFFECTIVE MARCH 9, 2015 bmchp.org | 888-566-0008 TO FIND A CODE OR WORD - While holding down the CTRL key, press the F key, type in Code, then press ENTER key Procedure Code Description 0213T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, cervical or thoracic; single level 0214T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, cervical or thoracic; second level (List separately in addition to code for primary procedure) 0215T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, cervical or thoracic; third and any additional level(s) (List separately in addition to code for primary procedure) 0216T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, lumbar or sacral; single level 0217T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, lumbar or sacral; second level (List separately in addition to code for primary procedure) 0218T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound
    [Show full text]
  • Defecography: Technique, Interpretation, and Current Use Arden M
    9 Defecography: Technique, Interpretation, and Current Use Arden M. Morris and Susan C. Parker Defecography, or evacuation proctography, is the on technique, interpretation, and implications dynamic study of expulsion of radiopaque mate- for specific patient populations. rial from the rectum, in order to assess changing anatomic relationships of the pelvic floor and associated organs during evacuation. In 1952, Indications for Testing Wallden 1 first described enteroceles, sigmoido- celes, and rectoceles, using roentgenogram Constipation techniques developed to evaluate patients with symptoms of obstructed defecation. He postu- Defecography was initially developed to assess lated that such outlet obstruction was due to an patients with complaints of constipation and a abnormally deep rectogenital pouch and could sensation of rectal outlet obstruction. The diag- be corrected surgically. However, performing nostic armamentarium has expanded to include these static studies using rectal, vaginal, and anal manometry, electromyography, and colonic small bowel contrast was a cumbersome, expen- transit time studies, all of which are crucial for sive, and embarrassing process for the patient. distinguishing end-organ versus total organ Recognizing the limitations of these studies, etiologies. Therefore, although the major indi- subsequent authors streamlined the procedure cation for performing defecography continues to over the ensuing three decades. be constipation, other complaints may occasion- Broden and Snellman2 proposed the use of ally warrant defecographic evaluation. Table 9.1 cineradiographic methods and a physiologic demonstrates the primary indications and their position, which contributed enormously to the proportionate prevalence among our referred simultaneous study of function and anatomy. patients. There is considerable overlap in many Several centers built radiolucent commodes with of these symptoms and diagnoses.
    [Show full text]
  • بنام خدا Defecography
    1/15/2019 بنام خدا Defecography 1 1/15/2019 Overview: • Definition • Anatomy • Method of assessment • Indication • Preparation • Instrument • Contrast media • Technique • Recording • Other technique • Technique pitfalls • Parameters • Abnormalities Findings Definition: Dynamic rectal examination (DRE) or defecography or proctography. • DRE provides a dynamic assessment of the act of defecation by recording the rectal expulsion of a barium paste. • DRE provides qualitative and quantitative information on the function of anorectal and pelvic floor function, and the effectiveness of the anal sphincter and rectal evacuation. 2 1/15/2019 Anatomy 3 1/15/2019 4 1/15/2019 5 1/15/2019 Method of assessment • Barium enema • Colon transit time • MR defecography Indications for dynamic rectal examination are: 1. Outlet obstruction (disorder of defecatory or rectal evacuation), caused by intussusception, enterocele or spastic pelvic floor syndrome. 2. To distinguish between anterior rectocele and enterocele. 3. Fecal incontinence combined with outlet obstruction in intra-anal intussusception. 6 1/15/2019 Preparation • No bowel preparation was used • It was deemed more physiological to observe how anorectal morphology altered during defaecation without preparation. • Two hours prior to the examination the patient ingests 135 ml of liquid barium contrast to opacify the small bowel. • In females the vagina is coated with 30 ml amidotrizoic acid 50% solution gel. • The use of tampons and gauzes soaked in barium should be avoided, because they can impaire pelvic-function. LEFT: Pathology is suspected because of a great distance between rectum and vagina. No oral contrast had been given. RIGHT: After ingestion of liquid barium contrast a large enterocele is seen.
    [Show full text]
  • Information for Patients Having a Sigmoid Colectomy
    Patient information – Pre-operative Assessment Clinic Information for patients having a sigmoid colectomy This leaflet will explain what will happen when you come to the hospital for your operation. It is important that you understand what to expect and feel able to take an active role in your treatment. Your surgeon will have already discussed your treatment with you and will give advice about what to do when you get home. What is a sigmoid colectomy? This operation involves removing the sigmoid colon, which lies on the left side of your abdominal cavity (tummy). We would then normally join the remaining left colon to the top of the rectum (the ‘storage’ organ of the bowel). The lines on the attached diagram show the piece of bowel being removed. This operation is done with you asleep (general anaesthetic). The operation not only removes the bowel containing the tumour but also removes the draining lymph glands from this part of the bowel. This is sent to the pathologists who will then analyse each bit of the bowel and the lymph glands in detail under the microscope. This operation can often be completed in a ‘keyhole’ manner, which means less trauma to the abdominal muscles, as the biggest wound is the one to remove the bowel from the abdomen. Sometimes, this is not possible, in which case the same operation is done through a bigger incision in the abdominal wall – this is called an ‘open’ operation. It does take longer to recover with an open operation but, if it is necessary, it is the safest thing to do.
    [Show full text]